A compounded synthetic peptide that a licensed provider may prescribe after clinical evaluation. Human research data is limited. Compounded medications are not FDA approved.
Compounded drugs are not FDA approved. FDA does not review compounded drugs for safety, effectiveness, or quality before marketing.

Images are for illustrative purposes only. Actual medication appearance, packaging, and labeling may vary by pharmacy.



TB-500 is a synthetic peptide based on thymosin beta-4, a protein the body makes that is involved in tissue repair. People often ask about it in connection with tissue repair and wound healing. A licensed provider decides whether it is appropriate for you after reviewing your health history and medications.
Human research on TB-500 is very limited. Most of what is known comes from laboratory and animal studies. It has not been shown in large, well-controlled clinical trials to be safe or effective for any use in people.
This medication is compounded. It is prepared for an individual patient based on a prescription. DrWell sources compounded peptides from prevetted 503A compounding pharmacies. Compounded medications are not FDA approved, which means the FDA has not evaluated their safety, effectiveness or quality.
Thymosin beta-4 is a natural protein that takes part in how cells move and how the body repairs tissue. TB-500 is a synthetic version designed around that protein. Laboratory and animal research has looked at its effects on cell migration and the formation of new blood vessels.
Those same processes raise a theoretical concern for people with cancer or conditions involving abnormal cell growth. These effects have not been established in humans. Your provider determines whether TB-500 is appropriate for you and how it should be used.
Your provider will review your health history and current medications before prescribing, and will explain the dose, schedule and how to use it. Follow-up visits are part of treatment.
Because human evidence is limited, no specific outcome can be promised. Individual responses vary, and results are not guaranteed.
Whether TB-500 is appropriate for you is a decision made by a licensed provider based on your health history, medications and goals. It is not appropriate for everyone, including people who are pregnant or nursing and people with a current or past cancer diagnosis or a condition involving abnormal cell growth, unless your provider directs otherwise.
This page is general information and is not medical advice.
Because human safety data are limited, the full range of side effects is not known. Reported or expected effects of peptide treatments in general include irritation, redness or discomfort where the medication is applied or injected, headache, dizziness, nausea and fatigue. Allergic reactions are possible.
Contact your provider promptly about swelling, trouble breathing, a spreading rash, or any symptom that concerns you.
This is not a complete list. Ask your provider for more information.
Compounded drugs are not FDA approved. FDA does not review compounded drugs for safety, effectiveness, or quality before marketing.
Medication availability, formulation, packaging and pharmacy fulfillment vary based on the patient's prescription and location.
Compounded medication, not FDA approved. This medication is compounded and is not FDA approved. The FDA has not evaluated compounded medications for safety, effectiveness or quality. It is prescribed for an individual patient by a licensed provider.
Pharmacy sourcing. DrWell obtains this medication from prevetted 503A compounding pharmacies. Sourcing from a vetted pharmacy does not make a compounded medication FDA approved and does not establish that it is safe or effective.
Limited human evidence. TB-500 has been studied mainly in laboratory and animal research. It has not been shown in large, well-controlled clinical trials to be safe or effective in people. Long-term safety is unknown.
Cell growth. TB-500 may affect cell movement and the formation of new blood vessels. The effect in people with cancer, a history of cancer or precancerous conditions is not known. Tell your provider about any of these.
Pregnancy and nursing. Do not use if you are pregnant, planning to become pregnant or nursing unless your provider directs otherwise.
Monitoring. Your provider should monitor your health during treatment.
Not medical advice. The information on this page is general and educational. It does not establish a provider relationship and does not replace a consultation with a licensed provider.
No. TB-500 is compounded, and compounded medications are not FDA approved. The FDA has not evaluated them for safety, effectiveness or quality.
A synthetic peptide based on thymosin beta-4, a protein the body makes that is involved in tissue repair.
Very little. Most research has been done in laboratory and animal studies. It has not been shown in large, well-controlled clinical trials to be safe or effective in people.
From prevetted 503A compounding pharmacies. That does not make it FDA approved, and it does not establish that it is safe or effective.
That has not been shown in people. No specific outcome can be promised, and individual responses vary.
Exactly as your provider directs. Do not change the dose or schedule on your own.
Contact your prescribing provider. Seek urgent care for swelling, trouble breathing or signs of a serious allergic reaction.